Synthesis, Characterization, Antimicrobial and Antioxidant Activities
The Open Medicinal Chemistry Journal, 2016, Volume 10 27
Model SMP3. The TLCs were carried out on Eastman Chromatogram Silica Gel Sheets (13181; 6060) with fluorescent
indicator. A mixture of ethyl acetate and methylene chloride (1:1) was used as eluent and iodine was used as revelator
for the chromatograms. The IR spectra were measured with a Fourier Transform Infrared spectrometer Brucker Alpha.
The UV spectra were recorded with a JENWAY 6715 UV-Vis Spectrophotometer. Combustion analyses were carried
out with a C, H, N, S Euro EA from Hekatech company, their results were found to be in good agreement (±0.3%) with
1
the calculated values. EIMS spectra were recorded on a double focusing mass spectrometer (Varian MAT 311A). H-
NMR spectra were recorded in DMSO-d6 on a Bruker DRX spectrometer operating at 500 MHz. 13C-NMR spectra were
recorded in DMSO-d6 on a Bruker DRX spectrometer operating at 125 MHz. TMS was used as internal reference.
Preparation of the Reagents and Starting Materials
All the reagents mentioned in this work were purchased from Aldrich and Fluka and were used without further
purification. Starting material 4 has been prepared according to literature procedures as published earlier [31a].
3-Amino-4H-thieno [3,4-c] [1] Benzopyran-4-one (4)
A mixture of 2-ceto-4-methyl-2H- [1] benzopyran-3-carbonitrile (4.65 g) and sulphur (1.22 g, in excess) in ethanol
(30 ml) was stirred using a magnetic plate shaker thermostated at 45 °C. Ammonia (6 ml) was added drop wise during
the first 10 min of the reaction. After 7 h of reaction, the resulting precipitate (5.08 g, 93%) was collected by filtration,
washed with distilled water and recrystallised in benzene to yield a yellow powder, mp 195–196 °C (Lit.18 198–199 °C,
from benzene); IR (potassium bromide): 3449 (-NH2); 1687 (C=O); 1603 and 1547 (C=C); 1224 (C-O); 1H NMR: 7.87
(1H; dd; J = 8.0; 1.5 Hz; H-8); 7.36 (1H; ddd; J = 8.0; 7.4; 1.8 Hz; H-6); 7.22-7.17 (2H; m; H-7 and H-5); 7.78 (2H; br
s; NH2); 6.89 (1H; s; thiophenic H); 13C(1H) NMR: 158.98 (C-2); 118.05 (C-2a); 166.70 (C-3); 151 (C-4a); 97.54
(C-5); 124.39 (C-6); 117.09 (C-7); 123.91 (C-8); 130.90 (C-8a); 98.07 (C-8b); 129.26 (C-9); ms: (EI) m ⁄ z (%) 217
(M+; 100%). Anal. Calcd for C11H7NO2S C: 60.83; H, 3.23; N, 6.45; S, 14.75. Found C, 61.17; H, 3.36; N, 6.49; S,
14.45.
Preparation of Diazonium Salt Solution
Dry sodium nitrite (2.07 g, 3 mmol) was slowly added over a period of 30 minutes to concentrated sulphuric acid
(10 mL) with occasional stirring. The solution was cooled to 0-5 °C. Compound 4 (0.22 g, 1 mmol) was dissolved in
DMSO (10 mL) and cooled to 0-5 °C. The nitrosyl sulphuric acid solution was added to the solution of 4 and the
temperature was maintained to 0-5 °C. The clear diazonium salt solution thus obtained consisting of the in situ formed
intermediates 5, was used immediately in the coupling reactions.
Procedure for the Preparation of the Coupling Product 6
Aniline (0.279 g; 3 mmol) was dissolved in DMSO (10 mL) and then cooled in an ice-bath at 0-5 °C. The
diazonium solution of 4 previously prepared was added drop wise over 1 hour, and then 15 mL of sodium acetate
solution (10%) was added in the mixture. The solid precipitate consisting of the previously reported [31b] (4H)-2-(p-
Aminophenylazo)thieno[3,4-c]chromen-4-one hydrogen sulfate (7) was collected on a filter and crystallised from
methanol to give the corresponding thienyl azo aryl dye. Work up of the resulted filtrate gave compound 6 in average
yield of 11%.
12,26,40-trioxa-43,44,45-trithia-2,3,16,17,30,31-hexaazadecacyclo [30.10.1.14,15.118,29.05,14. 06,11.019,28.020,25.033,42.034,39
pentatetraconta-1(42),2,4,6,8,10,14,16,18,20,22,24,28,30,32, 34, 36,38-octadecaene-13,27,41-trione (6).
]
Compound 6 (124 mg, 11%) was obtained as green yellowish powder. m.p. 213.5 °C; Rf = 0.43 in CH2Cl2/AcOEt
50% v/v; IR (potassium bromide): 2588 (=C-H), 1724 (C=O), 1677-1588 (CAr=CAr), 1544-1500 (thiophenic C=C), 1490
1
(-N=N-), 767 (=CAr-H) cm−1; λmax (DMSO) (Log ε): 400 (4.70), 282 (4.49), 229 (4.71); H-NMR (DMSO-d6, 500
MHz) δ 8.73 (dd, 3H, 7- H, 21-H and 35-H, J = 8 and 1.6 Hz), 7.85 (ddd, 3H, 9-H, 23-H and 37-H, J = 8.4, 6.4 and 1.6
Hz), 7.53 (dd, 3H, 10-H, 24-H and 38-H, J = 5.2 and 1.2 Hz), 7.51 (ddd, 3H, 8-H, 22-H and 36-H, J = 8.1, 7.2 and 1.2
Hz). 13C (1H)- NMR (DMSO-d6, 125 MHz) δ 135.5 (C-9, C-23 and C-37), 128.9 (C-7, C-21 and C-35), 125.4 (C-8,
C-22 and C-36), 117.1 (C-10, C-24 and C-38), 184.9 (C-13, C-27 and C-41), 153.7 (C-5, C-19 and C-33), 153.5 (C-14,
C-28 and C-42), 147.8 (C-1, C-15 and C-29), 119.9 (C-6, C-20 and C-34), 114.9 (C-4, C-18 and C-32), 154.9 (C-11,
C-25 and C-39); ms: (ESI+) m/z (%) 685 (29), 516 (40), 437 (65), 393 (19), 339 (42), 248 (94). Anal. Calcd. for
C33H12N6O6S3: C, 57.89; H, 1.77; N, 12.27; S, 14.05. Found C, 57.82; H, 1.75; N, 12.30; S, 14.11.